Match!
Hans-Christoph Diener
University of Duisburg-Essen
1,236Publications
99H-index
62.7kCitations
Publications 1256
Newest
#1Miney Paquette (McMaster University)H-Index: 5
Last.Robby Nieuwlaat (McMaster University)H-Index: 35
view all 14 authors...
Prospective studies evaluating persistence to nonvitamin K antagonist oral anticoagulants in patients with atrial fibrillation are needed to improve our understanding of drug discontinuation. The study objective was to evaluate if and when patients with newly diagnosed atrial fibrillation stop dabigatran treatment and to report outcomes following discontinuation. Patients prescribed dabigatran in diverse clinical practice settings were consecutively enrolled and followed for 2 years. Dabigatran ...
Source
Source
#1Pawel KermerH-Index: 25
#2Christoph C Eschenfelder (Boehringer Ingelheim)H-Index: 9
view all 73 authors...
BackgroundIdarucizumab is a monoclonal antibody fragment with high affinity for dabigatran reversing its anticoagulant effects within minutes. Thereby, patients with acute ischemic stroke who are o...
Source
#1Jan Lewis Brandes (Vandy: Vanderbilt University)H-Index: 30
Last.Daniel D. Mikol (Amgen)H-Index: 19
view all 13 authors...
ObjectiveTo assess the efficacy of erenumab across the spectrum of response thresholds (≥50%, ≥75%, 100%) based on monthly migraine days (MMD) reduction in patients with chronic migraine from a 12-...
Source
#1Peer Tfelt-Hansen (UCPH: University of Copenhagen)H-Index: 40
Last.Timothy J. Steiner (Imperial College London)H-Index: 49
view all 3 authors...
BackgroundIn trials of monoclonal antibodies against calcitonin gene-related peptide or its receptor for prevention of episodic migraine, we observed two problematic aspects: a) The graphic present...
Source
#1José M. Ferro (IMM: Instituto de Medicina Molecular)H-Index: 69
Last.Hans-Christoph DienerH-Index: 99
view all 15 authors...
Importance Patients with cerebral venous thrombosis (CVT) are at risk of recurrent venous thrombotic events (VTEs). Non–vitamin K oral anticoagulants have not been evaluated in randomized controlled trials in CVT. Objective To compare the efficacy and safety of dabigatran etexilate with those of dose-adjusted warfarin in preventing recurrent VTEs in patients who have experienced a CVT. Design, Setting, and Participants RE-SPECT CVT is an exploratory, prospective, randomized (1:1), parallel-group...
2 CitationsSource
#2Armin J. GrauH-Index: 40
Last.Stephan BaldusH-Index: 62
view all 3 authors...
Interventional patent foramen ovale (PFO) closure should be performed in patients aged 16 to 60 years (after extensive neurological and cardiological diagnostic work-up) with a history of cryptogenic ischaemic stroke and patent foramen ovale, with moderate or extensive right-to-left shunt.
Source
#1Michał MazurekH-Index: 9
#2Christine Teutsch (Boehringer Ingelheim)H-Index: 8
Last.Gregory Y.H. Lip (University of Liverpool)H-Index: 141
view all 14 authors...
GLORIA-AF is a large, ongoing, prospective, global registry program run in 3 phases, assessing long-term safety and effectiveness of dabigatran etexilate (dabigatran) in patients with newly diagnosed atrial fibrillation (AF) in clinical practice. This report provides the final analysis of 2-year clinical outcomes of the full cohort of 4873 patients prescribed dabigatran and followed for a mean of 18.0 +/- 9.4 months out of the 15,308 eligible patients enrolled in Phase II (2011-2014). The overal...
Source
#1Paolo MartellettiH-Index: 32
#2Todd J. Schwedt (Mayo Clinic)H-Index: 28
Last.Annik K. Laflamme (Novartis)H-Index: 2
view all 10 authors...
Objectives As part of the worldwide My Migraine Voice survey, this study evaluated the real-world healthcare resource utilization (HRU) and impact on work and activity impairment among people living with migraine in the United Kingdom (UK). Methods An analysis was conducted using UK subset data from My Migraine Voice survey: a worldwide, cross-sectional, online study including respondents (≥18 years), with ≥4 monthly migraine days, with 90% having used preventive migraine treatment in the preced...
Source
#1Michał MazurekH-Index: 9
#2Jonathan L. Halperin (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 120
Last.Gregory Y.H. Lip (University of Liverpool)H-Index: 141
view all 14 authors...
Source
12345678910